Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer

Retrospective observational study of salvage line ramucirumab monotherapy for patients with advanced gastric cancer

Abstract Background Ramucirumab monotherapy as a second-line treatment for advanced gastric cancer (AGC) prolongs survival compared to the best supportive care. However, in clinical practice, ramucirumab monotherapy is sometimes used as third- or later-line treatment for AGC refractory to fluoropyri...

Full description

Bibliographic Details
Main Authors: Sadayuki Kawai, Naoki Fukuda, Shun Yamamoto, Seiichiro Mitani, Katsuhiro Omae, Takeru Wakatsuki, Ken Kato, Shigenori Kadowaki, Daisuke Takahari, Narikazu Boku, Kei Muro, Nozomu Machida
Format: Article
Language:English
Published: BMC 2020-04-01
Series:BMC Cancer
Subjects:
Stomach neoplasms
Drug therapy
Salvage therapy
Ramucirumab
Online Access:http://link.springer.com/article/10.1186/s12885-020-06865-7

Internet

http://link.springer.com/article/10.1186/s12885-020-06865-7

Similar Items